04 May, 2021 02:18 PM
In accordance with Listing Rule 3.13.2 and section 251AA of the Corporations Act, we advise details of the resolutions and the proxies received in respect of each resolution in the attached voting r...read more
04 May, 2021 11:23 AM
Good morning ladies and gentlemen, my name is James McBrayer, the Managing Director of Cyclopharm.
Slide 7 – Financial Highlights
To begin, I would like to provide a review of our financ...read more
04 May, 2021 11:20 AM
Good morning ladies and gentlemen, and fellow shareholders.
Thank you for joining us for today’s virtual Annual General Meeting of Cyclopharm Limited. My name Is David Heaney, Chairman of t...read more
23 Apr, 2021 12:24 PM
Chimeric Therapeutics Limited (“the Company”) (ASX: CHM), a clinical stage cell therapy company, is pleased to provide a summary of its activities for the quarter ended 31 March 2021.
22 Apr, 2021 08:45 AM
Chimeric Therapeutics (ASX:CHM, “Chimeric” or the “Company”), a clinical stage cell therapy company, is pleased to provide an update to its recent announcement and confirm th...read more
18 Mar, 2021 09:04 AM
Chimeric Therapeutics, a clinical stage cell therapy company, is pleased to announce the successful completion of the planned dosing of the first patient cohort (n=4) in the phase 1 dose escalation ...read more
25 Feb, 2021 12:29 PM
Cyclopharm Limited (ASX: CYC) is pleased to provide the following update on its business and financial performance for FY2020, including progress towards gaining United States Food and Drug Administ...read more